Two deals set the tone in deal value last week—Jazz Pharmaceuticals buying GW Pharmaceuticals for $7.2 billion and CoreLogic being acquired for $6.2 billion by Stone Point Capital and Insight Partners. But there were also several SPACs also made buys that had valuations over $1 billion.